Table 1

Trisomy 8 CD34 cells are primarily annexin+, and cell-cycle analysis of these demonstrated no DNA degradation

Annexin, %
Annexin+, %
Patient no.Trisomy 8Subgenomic DNAG1SG2Trisomy 8Subgenomic DNAG1SG2Positive TUNEL assay
15 80 15 85 97 
17 88 10 83 97 10 
21 10 83 15 58 68 ND 
98 98 98 
13 90 10 70 97 
ND ND ND ND 43 ND ND ND ND 20 
23 13 ND ND ND ND 87 ND ND ND ND ND 
10 ND ND ND ND 85 ND ND ND ND ND 
34 ND ND ND ND 97 ND ND ND ND 
Mean healthy control* 98 56 40 68 
Annexin, %
Annexin+, %
Patient no.Trisomy 8Subgenomic DNAG1SG2Trisomy 8Subgenomic DNAG1SG2Positive TUNEL assay
15 80 15 85 97 
17 88 10 83 97 10 
21 10 83 15 58 68 ND 
98 98 98 
13 90 10 70 97 
ND ND ND ND 43 ND ND ND ND 20 
23 13 ND ND ND ND 87 ND ND ND ND ND 
10 ND ND ND ND 85 ND ND ND ND ND 
34 ND ND ND ND 97 ND ND ND ND 
Mean healthy control* 98 56 40 68 

CD34+, annexin+ BMMNCs obtained from patients with trisomy 8 and purified by flow cytometry were analyzed by FISH. Samples from these patients, which were subjected to cell-cycle analysis or TUNEL assay as described in “Patients, methods, and materials,” showed little DNA degradation. Results were compared with an apoptotic control (normal BMMNCs prompted to undergo apoptosis by coculture with IFNγ [1000 U/mL] and Fas agonist).

ND indicates not done.

* N = 5.

or Create an Account

Close Modal
Close Modal